The Cardiovascular, Renal, and Metabolism Center in the Department of Internal Medicine is proud to highlight Sydney Hartsell, MD, MPH, Assistant Professor of Internal Medicine, on the acceptance of a new publication in the Journal of the American Society of Nephrology (JASN).
The study, titled "Comparative Effectiveness of SGLT2i and GLP-1 RA on Kidney and Cardiovascular Outcomes by Kidney Failure Risk," looks at an important question for patient care: which of two newer types of medications works better for people with different levels of kidney disease severity. These medications—SGLT2 inhibitors and GLP-1 receptor agonists—are increasingly used to treat patients with kidney and metabolic conditions at cardiovascular risk. This research helps doctors better understand how to choose the right treatment for different patients, improving care and outcomes.
This publication also marks an important milestone for Dr. Srinivasan Beddhu's research team, as it represents the first major first-author paper for Dr. Hartsell, an achievement that reflects Dr. Beddhu's strong commitment to mentorship and developing the next generation of physician-scientists. The publication presents findings from Dr. Hartsell's T32 training grant project during her time as a research fellow, supported by PIs Drs. Stavros Drakos and Robin Shaw with the University of Utah's Nora Eccles Harrison Cardiovascular and Research Training Institute (CVRTI). Drs. Tom Greene and Jincheng Shen, Division of Epidemiology, also made significant contributions to this paper.
The Cardiovascular, Renal and Metabolism Center, led by Dr. Srinivasan Beddhu, Professor of Internal Medicine and Dialysis Research Foundation Presidential Endowed Chair, and Dr. Stavros Drakos, Professor of Internal Medicine and Edna Benning Presidential Endowed Chair, is committed to advancing scientific discoveries in Cardiovascular, Kidney and Metabolic (CKM) Syndrome.
This accomplishment also highlights the Division of Nephrology and Hypertension leadership in kidney and cardiovascular research and the impact of collaborative, multidisciplinary work. Additional details can be found on the Cardiovascular, Renal, and Metabolism Center (CRMC) website.